Does Rallies show Form 4 insider transactions for PMVP?

Yes. Rallies tracks PMVP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PMVP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PMVP. It does not provide personalized investment advice.

PMVP (PMV Pharmaceuticals, Inc) Stock Analysis - Insider Trades

PMV Pharmaceuticals, Inc (PMVP) is a publicly traded Healthcare sector company. As of May 21, 2026, PMVP trades at $1.31 with a market cap of $66.66M and a P/E ratio of -0.88. PMVP moved +0.00% today. Year to date, PMVP is +7.38%; over the trailing twelve months it is +40.74%. Its 52-week range spans $0.81 to $1.88. Analyst consensus is strong buy with an average price target of $4.50. Rallies surfaces PMVP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PMVP stock inside the company?

Recent PMVP insider activity includes ORBIMED ADVISORS LLC sold 1.00M, ORBIMED ADVISORS LLC sold 500.00K, Ticktin Robert sold 23.15K, Jalota Deepika sold 33.06K, and Carulli Michael sold 28.25K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PMVP Key Metrics

Key financial metrics for PMVP
Metric	Value
Price	$1.31
Market Cap	$66.66M
P/E Ratio	-0.88
EPS	$-1.49
Dividend Yield	0.00%
52-Week High	$1.88
52-Week Low	$0.81
Volume	0
Avg Volume	0
Revenue (TTM)	$5.38M
Net Income	$-78.34M
Gross Margin	0.00%

Recent PMVP Insider Trades

ORBIMED ADVISORS LLC sold 1.00M (~$1.52M) on Oct 23, 2025.
ORBIMED ADVISORS LLC sold 500.00K (~$900.00K) on Sep 10, 2025.
Ticktin Robert sold 23.15K (~$24.65K) on Jul 1, 2025.
Jalota Deepika sold 33.06K (~$35.20K) on Jul 1, 2025.
Carulli Michael sold 28.25K (~$30.08K) on Jul 1, 2025.

Latest PMVP News

PMV Pharmaceuticals Gains FDA ODD, Reports 44% ORR and $93.5M Cash — May 12, 2026
PMV Pharma Appoints Laurie Stelzer as Board Chair Ahead of NDA Filing — Apr 22, 2026
PMV Pharma Reports $112.9M Cash Runway, FDA Orphan-Drug Status and Rezatapopt NDA in Q1 2027 — Mar 6, 2026
PMV Pharma’s Rezatapopt Phase 1 Shows Safety and Responses in 77 Patients — Feb 26, 2026

PMVP Analyst Consensus

3 analysts cover PMVP: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.50.

Common questions about PMVP

Who is trading PMVP stock inside the company?: Recent PMVP insider activity includes ORBIMED ADVISORS LLC sold 1.00M, ORBIMED ADVISORS LLC sold 500.00K, Ticktin Robert sold 23.15K, Jalota Deepika sold 33.06K, and Carulli Michael sold 28.25K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PMVP?: Yes. Rallies tracks PMVP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PMVP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PMVP. It does not provide personalized investment advice.